Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125434932 | 12543493 | 2 | F | 20160706 | 20160711 | 20160720 | EXP | GB-PFIZER INC-2015230874 | PFIZER | 57.00 | YR | Y | 0.00000 | 20160720 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125434932 | 12543493 | 1 | PS | DOCETAXEL. | DOCETAXEL | 1 | 60 MG/M2, EVERY 5 DAYS | Y | 202356 | 60 | MG/M**2 | ||||||||
125434932 | 12543493 | 2 | SS | DOCETAXEL. | DOCETAXEL | 1 | 75 MG/M2, UNK | Y | 202356 | 75 | MG/M**2 | ||||||||
125434932 | 12543493 | 3 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Unknown | UNK | Y | 0 | |||||||||
125434932 | 12543493 | 4 | SS | PERJETA | PERTUZUMAB | 1 | Unknown | UNK | Y | 0 | |||||||||
125434932 | 12543493 | 5 | SS | KADCYLA | ADO-TRASTUZUMAB EMTANSINE | 1 | Unknown | UNK | 0 | ||||||||||
125434932 | 12543493 | 6 | C | FLUOROURACIL. | FLUOROURACIL | 1 | 0 | ||||||||||||
125434932 | 12543493 | 7 | C | EPIRUBICIN | EPIRUBICIN | 1 | 0 | ||||||||||||
125434932 | 12543493 | 8 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125434932 | 12543493 | 1 | HER-2 positive breast cancer |
125434932 | 12543493 | 3 | HER-2 positive breast cancer |
125434932 | 12543493 | 4 | HER-2 positive breast cancer |
125434932 | 12543493 | 5 | HER-2 positive breast cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125434932 | 12543493 | HO |
125434932 | 12543493 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125434932 | 12543493 | Clostridium difficile infection | |
125434932 | 12543493 | Disease progression | |
125434932 | 12543493 | HER-2 positive breast cancer | |
125434932 | 12543493 | Lower respiratory tract infection | |
125434932 | 12543493 | Neutropenic infection | |
125434932 | 12543493 | Varicella |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |